1. Home
  2. DENN vs PRQR Comparison

DENN vs PRQR Comparison

Compare DENN & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Denny's Corporation

DENN

Denny's Corporation

HOLD

Current Price

$6.20

Market Cap

318.8M

ML Signal

HOLD

Logo ProQR Therapeutics N.V.

PRQR

ProQR Therapeutics N.V.

HOLD

Current Price

$2.33

Market Cap

250.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DENN
PRQR
Founded
1953
2012
Country
United States
Netherlands
Employees
3800
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
318.8M
250.7M
IPO Year
1989
2014

Fundamental Metrics

Financial Performance
Metric
DENN
PRQR
Price
$6.20
$2.33
Analyst Decision
Buy
Strong Buy
Analyst Count
6
7
Target Price
$5.45
$8.14
AVG Volume (30 Days)
2.3M
540.5K
Earning Date
11-03-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.20
N/A
Revenue
$457,212,000.00
$18,859,556.00
Revenue This Year
$6.56
N/A
Revenue Next Year
$1.56
N/A
P/E Ratio
$31.61
N/A
Revenue Growth
0.93
N/A
52 Week Low
$2.85
$1.07
52 Week High
$7.66
$3.46

Technical Indicators

Market Signals
Indicator
DENN
PRQR
Relative Strength Index (RSI) 66.03 53.75
Support Level $6.13 $2.15
Resistance Level $6.20 $2.42
Average True Range (ATR) 0.02 0.19
MACD -0.04 0.04
Stochastic Oscillator 91.67 79.70

Price Performance

Historical Comparison
DENN
PRQR

About DENN Denny's Corporation

Denny's Corp is America's franchised full-service restaurant chains based on the number of restaurants. The company owns and operates the Denny's brand and the Keke's Breakfast Cafe brand. It provides Pancakes, Appetizers & Soups, Sandwiches & Salads, Breakfast Melts, Omelets, and others. The company generates its revenue from two sources: the sale of food and beverages and the collection of royalties, advertising revenue, initial and other fees, including occupancy revenue, from restaurants operated by their franchisees. Geographically operates in USA states as well as globally like Canada, Mexico, Guatemala, Indonesia, United Kingdom, New Zealand and others. Maximum revenue is from USA and Canada.

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.

Share on Social Networks: